Elevated numbers of circulating endothelial cells in renal transplant recipients

Transplantation

Volumn 76, Issue 1, 2003, Pages 1-4

  Woywodt, Alexander ^a   Schroeder, Maik ^a   Gwinner, Wilfried ^a   Mengel, Michael ^a   Jaeger, Mark ^a   Schwarz, Anke ^a   Haller, Hermann ^a   Haubitz, Marion ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ANTIBODY; AZATHIOPRINE; CALCINEURIN INHIBITOR; CD146 ANTIBODY; CYCLOSPORIN A; LECTIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL COUNT; CELL DAMAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULITIS;

ACUTE DISEASE; ANTIGENS, CD; BIOPSY; BLOOD CELLS; CREATININE; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEINURIA; RENAL CIRCULATION;

EID: 0038299462     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000074569.65127.26     Document Type: Article

References (23)

1. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590.
2. Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091-1099.
3. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: New insights into an old concept. Eur J Haematol 2000; 65: 215-220.
4. Woywodt A, Streiber F, Regelsberger H, et al. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 2003; 306: 206-210.
5. Bardin N, George F, Mutin M, et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531-539.
6. Anfosso F, Bardin N, Vivier E, et al. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 2001; 276: 1564-1569.
7. Kooijmans-Coutinho MF, Hermans J, Schrama E, et al. Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts: Predisposing factors, histology, immunohistochemistry, and relation to outcome. Transplantation 1996; 61: 1338-1344.
8. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-37.
9. Woywodt A, Bahlmann FH, de Groot K, et al. Circulating endothelial cells: Life, death and detachment of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-1730.
10. van Son WJ, Brijker F, Elema JD, et al. Elevated factor VIII as a marker for vascular type of rejection after renal transplantation. Transplant Proc 1997; 29: 161-163.
11. Kas-Deelen AM, de Maar EF, Harmsen MC, et al. Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: Effect of acute rejection. J Infect Dis 2000; 181: 721-724.
12. Herzenberg AM, Gill JS, Djurdjev O, et al. C4d deposition in acute rejection: An independent long-term prognostic factor. J Am Soc Nephrol 2002; 13: 234-241.
13. Bishop GA, Waugh JA, Landers DV, et al. Microvascular destruction in renal transplant rejection. Transplantation 1989; 48: 408-414.
14. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313.
15. Kendrick E. Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis 2001; 38: S36-S43.
16. Morris ST, McMurray JJ, Rodger RS, et al. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 2000; 57: 1100-1106.
17. Ovuworie CA, Fox ER, Chow CM, et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 2001; 72: 1385-1388.
18. Sudhir K, MacGregor JS, DeMarco T, et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation 1994; 90: 3018-3023.
19. Diederich D, Skopec J, Diederich A, et al. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994; 23: 957-961.
20. Moore LC, Mason J, Feld L, et al. Effect of cyclosporine on endothelial albumin leakage in rats. J Am Soc Nephrol 1992; 3: 51-57.
21. Kochi S, Takanaga H, Matsuo H, et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. Life Sci 2000; 66: 2255-2260.
22. Collins P, Wilkie M, Razak K, et al. Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells. Transplantation 1993; 56: 1218-1223.
23. Grieff M, Loertscher R, Shohaib SA, et al. Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation 1993; 56: 880-884.